Why France's national medication agency is sanctioning two pharmaceutical companies for covert advertising
- Posted on May 12, 2026
- By Le Monde
- 1 Views
- 1 min read
Why France's national medication agency is sanctioning two pharmaceutical companies for covert advertising
France's National Agency for the Safety of Medicine and Health Products (ANSM) has ruled that the campaigns led by Novo Nordisk and Eli Lilly, which were presented as awareness initiatives, amounted to promotion of their products. Such advertising is forbidden in France.
